ArticleBMC cancer2020

GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment.

Annat Raiter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.